SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001659617-18-000046
Filing Date
2018-04-27
Accepted
2018-04-27 16:01:17
Documents
1
Period of Report
2018-04-27
Effectiveness Date
2018-04-27

Document Format Files

Seq Description Document Type Size
1 DEF 14A defproxydef14a2018.htm DEF 14A 605297
  Complete submission text file 0001659617-18-000046.txt   606347
Mailing Address 2575 WEST BELLFORT SUITE 333 HOUSTON TX 77054
Business Address 2575 WEST BELLFORT SUITE 333 HOUSTON TX 77054 713-300-5160
Moleculin Biotech, Inc. (Filer) CIK: 0001659617 (see all company filings)

IRS No.: 474671999 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37758 | Film No.: 18783738
SIC: 2834 Pharmaceutical Preparations